Prescription Drugs - Puerto Rico

  • Puerto Rico
  • Puerto Rico is projected to witness a considerable increase in revenue within the Prescription Drugs market.
  • By 2024, the revenue is expected to reach US$266.60m.
  • Furthermore, an annual growth rate (CAGR 2024-2029) of 1.89% is anticipated, resulting in a market volume of US$292.70m by 2029.
  • In comparison to other countries globally, United States is expected to generate the highest revenue in the Prescription Drugs market, amounting to US$358.90bn in 2024.
  • When considering the population figures, it can be observed that per person revenues of US$81.57 are generated in Puerto Rico in 2024 within the Prescription Drugs market.
  • Pharmaceutical companies in Puerto Rico are leveraging the island's skilled workforce and tax incentives to become a hub for the manufacturing of prescription drugs.

Key regions: Japan, China, Europe, Australia, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Prescription Drugs (Pharmacies) market in Puerto Rico is experiencing significant growth and development. Customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors all contribute to this positive trajectory. Customer preferences play a crucial role in the development of the Prescription Drugs (Pharmacies) market in Puerto Rico. Customers are increasingly seeking convenience and accessibility when it comes to purchasing prescription drugs. This has led to a rise in the popularity of online pharmacies and home delivery services. Customers also prioritize competitive prices and a wide range of product options. Pharmacies that can meet these preferences are likely to attract and retain a larger customer base. Trends in the market further contribute to the growth of the Prescription Drugs (Pharmacies) market in Puerto Rico. One notable trend is the increasing demand for generic drugs. Generic drugs offer the same therapeutic benefits as brand-name drugs but at a lower cost. This affordability factor has driven the demand for generic drugs, as customers seek to reduce their healthcare expenses. Pharmacies that offer a wide selection of generic drugs are likely to see increased foot traffic and sales. Another trend in the market is the growing focus on preventive healthcare. Customers are becoming more proactive in managing their health and are seeking out prescription drugs that can help prevent or manage chronic conditions. This trend has led to an increased demand for medications such as statins for cholesterol management and blood pressure medications. Pharmacies that can cater to this demand by offering a range of preventive medications are likely to see growth in their customer base. Local special circumstances also contribute to the development of the Prescription Drugs (Pharmacies) market in Puerto Rico. The island's aging population is a significant factor driving the demand for prescription drugs. As the population ages, the prevalence of chronic conditions increases, leading to a higher demand for medications. Additionally, Puerto Rico's status as a popular tourist destination also impacts the market. Tourists often require prescription medications during their stay, leading to increased sales for pharmacies. Underlying macroeconomic factors also play a role in the development of the Prescription Drugs (Pharmacies) market in Puerto Rico. The island's economic stability and healthcare system have a direct impact on the affordability and accessibility of prescription drugs. Government policies and regulations regarding healthcare and pharmaceuticals can influence pricing and availability. Economic growth and stability can also impact consumer spending power and willingness to purchase prescription drugs. In conclusion, the Prescription Drugs (Pharmacies) market in Puerto Rico is experiencing growth and development due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Pharmacies that can cater to customer preferences for convenience, competitive prices, and a wide range of products are likely to thrive. The increasing demand for generic drugs and preventive healthcare also presents opportunities for growth. Local special circumstances, such as the aging population and tourism, further contribute to the market's development. Finally, underlying macroeconomic factors, including economic stability and government policies, impact the affordability and accessibility of prescription drugs.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)